CBPO [China Biologic Products] 8-A12B: (Original Filing)
[]
CBPO [China Biologic Products] IRANNOTICE: (Original Filing)
[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China February 23, 2017 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat ]
CBPO [China Biologic Products] IRANNOTICE: China Biologic Products, Inc. 8th Floor, Jialong International
[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China February 23, 2017 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat ]
CBPO [China Biologic Products] 10-K: (Original Filing)
[Annual Report on Form 10-K Year Ended December 31, 2016 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 45 Item 2. Properties 45 Item 3. Legal Proceedings 46 Item 4. Mine Safety Disclosures 48 PART II Item 5. 49 Item 6. Selected Financial Data ]
CBPO [China Biologic Products] 10-K: Annual Report on Form 10-K Year Ended December
[Annual Report on Form 10-K Year Ended December 31, 2016 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 45 Item 2. Properties 45 Item 3. Legal Proceedings 46 Item 4. Mine Safety Disclosures 48 PART II Item 5. 49 Item 6. Selected Financial Data ]
CBPO [China Biologic Products] 8-K: (Original Filing)
[FOR RELEASE February 23, 2017 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 -- 4Q16 Total Sales Up 13.6% YoY to $77.6 Million and Net Income Up 19.0% YoY to $19.4 Million in USD terms, or Total Sales Up 21.7% YoY and Non-GAAP Adjusted Net Income Up 40.7% YoY in]
CBPO [China Biologic Products] 8-K: FOR RELEASE February 23, 2017 China Biologic Reports
[FOR RELEASE February 23, 2017 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 -- 4Q16 Total Sales Up 13.6% YoY to $77.6 Million and Net Income Up 19.0% YoY to $19.4 Million in USD terms, or Total Sales Up 21.7% YoY and Non-GAAP Adjusted Net Income Up 40.7% YoY in]
CBPO [China Biologic Products] SC 13G: (Original Filing)
[Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 81,762 Item 6: 0 Item 7: 1,474,444 Item 8: 0 Item 9: 1,474,444 Item 11: 5.433% Item 12: HC Cusip #16938C106 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 5: 0]
CBPO [China Biologic Products] SC 13G: Item 1: Reporting Person – FMR LLC Item
[Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 81,762 Item 6: 0 Item 7: 1,474,444 Item 8: 0 Item 9: 1,474,444 Item 11: 5.433% Item 12: HC Cusip #16938C106 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 5: 0]
CBPO [China Biologic Products] SC 13G: 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.
[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) SMALLCAP World Fund, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Maryland 5 SOLE VOTING POWER NONE 6 SHARED VOTING POW]
